Study reveals strategy to create COVID-19 drugs to inhibit virus's entry and replication

SARS-CoV-2, the respiratory virus that causes COVID-19, attacks the body in multiple steps. Gaining entry into cells deep within the lungs and hijacking the human host cell's machinery to churn out copies of itself are two of the earliest steps—both essential for viral infection.